A groundbreaking study reveals that artificial intelligence can design proteins to combat deadly snake venom, potentially revolutionizing antidote creation. Researchers Timothy Jenkins and David Baker collaborated to develop a cost-effective method using AI, particularly a generative model named RFdiffusion. Traditional antidote production relies on harvesting snake venom and injecting large animals for antibodies, which is time-consuming and inefficient. Their lab tests demonstrated success in using AI-designed proteins to neutralize venom in mice. This innovation marks a significant advancement in medical science and the use of AI in drug development.